GL1X · GenesisL1 explorer

MolNFT v1 · #2542 · protein

Drug-protein interactions: structure of sulfonamide drug complexed with human carbonic anhydrase I

1BZM: “Drug-protein interactions: structure of sulfonamide drug complexed with human carbonic anhydrase I”. X-ray diffraction, 2 ligands (MZM, ZN), 2 pockets (best druggability 0.55). MolNFT v1 #2542 on GenesisL1: 3D structure, binding…

PDB
1BZM
Type
protein
Length
260 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Carbonic anhydrase I
EC
4.2.1.1
UniProt
P00915
Ligands
MZM, ZN
Pockets
2 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 17% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACarbonic anhydrase I (EC 4.2.1.1)protein26017% helix, 30% strandP00915

Ligands and binding sites

  • MZM · N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11830.550.7923MZM
21200.430.7719empty

Compared structures

  • 1BZM · Drug-protein interactions: structure of sulfonamide drug complexed with human carbonic… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00915 · AlphaFold monomer V2.0 prediction for carbonic anhydrase 1 (P00915) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.